We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-5.64%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$741B
AUM Growth
-$68.4B
Cap. Flow
-$3.25B
Cap. Flow %
-0.44%
Top 10 Hldgs %
15.48%
Holding
8,434
New
238
Increased
3,520
Reduced
3,560
Closed
255

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$2.61B
2
EPAM icon
EPAM Systems
EPAM
+$1.48B
3
TWLO icon
Twilio
TWLO
+$1.35B
4
AAPL icon
Apple
AAPL
+$1.24B
5
TWTR
Twitter, Inc.
TWTR
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Healthcare 9.76%
3 Financials 9.11%
4 Consumer Discretionary 8.41%
5 Communication Services 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNCA
6651
DELISTED
Genocea Biosciences, Inc.
GNCA
$35K ﹤0.01%
28,163
+14,527
+107% +$15.8K
AAAU icon
6652
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.68B
$34K ﹤0.01%
1,798
-1,088
-38% -$20.3K
CCLD icon
6653
CareCloud
CCLD
$104M
$34K ﹤0.01%
6,578
+1,678
+34% +$9.2K
CDRO icon
6654
Codere Online
CDRO
$410M
$34K ﹤0.01%
6,700
+6,693
+95,614% +$39K
DRSK icon
6655
Aptus Defined Risk ETF
DRSK
$1.54B
$34K ﹤0.01%
+1,219
New +$34.5K
GLL icon
6656
ProShares UltraShort Gold
GLL
$102M
$34K ﹤0.01%
306
+121
+65% +$14.4K
JHEM icon
6657
John Hancock Multifactor Emerging Markets ETF
JHEM
$1.03B
$34K ﹤0.01%
1,244
+813
+189% +$23.1K
SLE icon
6658
Super League Enterprise
SLE
$5.44M
$34K ﹤0.01%
2
-6
-75% -$119K
SUSL icon
6659
iShares ESG MSCI USA Leaders ETF
SUSL
$1.21B
$34K ﹤0.01%
428
-400
-48% -$31.3K
CIRC
6660
Circle8 Group
CIRC
$63M
$34K ﹤0.01%
610
-2,311
-79% -$134K
VAXX
6661
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$34K ﹤0.01%
7,817
-3,385
-30% -$18.7K
LVOX
6662
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$34K ﹤0.01%
11,334
+5,969
+111% +$26.2K
CFIVU
6663
DELISTED
CF Acquisition Corp. IV Unit
CFIVU
$34K ﹤0.01%
3,396
-1,457
-30% -$14.5K
NSTC.U
6664
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$34K ﹤0.01%
3,450
STRY
6665
DELISTED
Starry Group Holdings, Inc.
STRY
$34K ﹤0.01%
+4,100
New +$35.4K
AUUD
6666
Auddia
AUUD
$5.95M
$33K ﹤0.01%
5
+4
+400% +$23.2K
CATX icon
6667
Perspective Therapeutics
CATX
$372M
$33K ﹤0.01%
9,063
+1,440
+19% +$5.25K
FLNT
6668
Fluent
FLNT
$129M
$33K ﹤0.01%
2,644
-5,565
-68% -$56.8K
HOWL icon
6669
Werewolf Therapeutics
HOWL
$18.6M
$33K ﹤0.01%
7,630
-433
-5% -$3.03K
INCR
6670
Intercure
INCR
$57.1M
$33K ﹤0.01%
4,601
LYRA
6671
DELISTED
LYRA THERAPEUTICS INC
LYRA
$33K ﹤0.01%
162
-27
-14% -$5.93K
NEPH icon
6672
Nephros
NEPH
$47.4M
$33K ﹤0.01%
7,525
+1,049
+16% +$4.98K
RDCM icon
6673
Radcom
RDCM
$173M
$33K ﹤0.01%
2,572
+691
+37% +$8.21K
TARA icon
6674
Protara Therapeutics
TARA
$230M
$33K ﹤0.01%
6,556
-21,344
-77% -$112K
STLN
6675
Starling Oncology, Inc. Common Stock
STLN
$644M
$33K ﹤0.01%
4,475
+3,543
+380% +$23.9K

Similar funds

Morgan Stanley's Q1 2022 Portfolio in Review

As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
  • Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
  • Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
  • Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
  • Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
  • Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
  • Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.